Here are four facts:
1. The market value is expected to reach a $1.5 billion value by 2022.
2. Key factors contributing to its rapid growth include the increasing geriatric population prone to chronic diseases as well as increasing number of emergency cases and growing demand for short stay ambulatory day care surgical procedure.
3. The market comprises products such as sevoflurane, isoflurane and desflurane.
4. The Sevoflurane market segment was the largest product group in 2014, accounting for over 70 percent of the demand.
More articles on anesthesia:
Dr. Peter Goldstein named to the Association of University Anesthesiologists’ Scientific Advisory Board: 4 quick facts
Allied Anesthesia, St. Jude Medical Center partner: 4 takeaways
CMS proposes new joint replacement bundled payment program: 6 things anesthesiologists need to know
